Professionals Speaking
Related Practices

European Patent Office Perspectives on Life Sciences Patent Examination

A Steptoe-sponsored event
September 28, 2017

Please join Steptoe's Intellectual Property group as we host representatives from the Antibody and Small Molecular Directorates of the European Patent Office (EPO) on Thursday, September 28, for a discussion on recent developments in EP case law and new EPO examination initiatives.

Date:

Thursday, September 28, 2017

Time:

2:00 p.m. - 3:30 p.m. ET


If you would like to receive a link to the recording of the webinar, please let us know by requesting a copy here. 

Featured speakers:

  • Klaus-Peter Döpfer, Director, EPO
  • Thomas Eijkenboom, Director, EPO
  • Oskar Lechner, Examiner, EPO
  • Carmen Österle, Examiner, EPO
  • Maria Antonia Ansaldo, Team Manager, EPO
This webinar will be moderated by Steptoe partner Ying Li

Topics for discussion will include:
  • Updates on examination of antibody epitope claims and humanized antibody claims
  • Common issues as to priority entitlement, added subject-matter (claim dependencies, singling out, reference documents, and divisional applications)
  • Updates on examination of RNAi claims
  • A new decision on technical effects of small molecule drugs
  • The EPO’s recent “Early Certainty” initiative

CLE credit is pending in AZ, CA, NY, and VA.